Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $879,239 - $1.12 Million
-8,671 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$113.81 - $129.46 $166,276 - $189,141
-1,461 Reduced 14.42%
8,671 $1.11 Million
Q2 2018

Aug 10, 2018

BUY
$101.14 - $118.31 $16,283 - $19,047
161 Added 1.61%
10,132 $1.15 Million
Q1 2018

May 09, 2018

SELL
$107.21 - $151.94 $269,954 - $382,584
-2,518 Reduced 20.16%
9,971 $1.12 Million
Q4 2017

Feb 12, 2018

SELL
$118.58 - $151.28 $90,002 - $114,821
-759 Reduced 5.73%
12,489 $1.85 Million
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $1.52 Million - $1.81 Million
13,248
13,248 $1.55 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Liberty Mutual Group Asset Management Inc. Portfolio

Follow Liberty Mutual Group Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.